LONDON, April 8: As preparations for the second edition of the London Biotechnology Show (LBS25) gather momentum, organisers have announced that registration for the event will be free, a move

The rise of immuno-oncology is transforming cancer treatment, leveraging the body's immune system to combat the disease. In a recent interview, Dr. Alexander Ariel Padrón González, Director of

19 March, 2024: Leeds-based medtech startup, Eventum Orthopaedics, has secured £3.8 million in follow-on investment to expand its groundbreaking surgical device, QuadSense. Designed to enhance knee replacement procedures, QuadSense

13 March, 2025: The University of Liverpool has introduced the Eye Cancer Artificial Intelligence Digital Bioresource (EYE-CAN-AID)—a groundbreaking initiative aimed at improving early detection and treatment of rare eye

10 March 2025: The UK Government has accepted the majority of recommendations from the Regulatory Horizons Council (RHC) regarding the regulation of artificial intelligence (AI) in medical devices, aiming to

Denham, 7 March 2025 – ITK Engineering, a global technology firm and subsidiary of Robert Bosch, is expanding into the UK MedTech sector. With 30 years of expertise in software and

Basel, 12 March 2025 – Roche has entered into an exclusive collaboration and licensing agreement with Zealand Pharma (a Danish biotechnology research company) to co-develop and co-commercialise Zealand Pharma’s amylin

The intricate relationship between the gut and brain has become a focal point of scientific inquiry, revealing profound implications for mental health. As research advances, the field of psychobiotics—probiotics

The most accurate and sensitive screening test available and will be transformative in tackling prostate cancer in men who may have no idea if anything is wrong with them.

Geneva, February 17, 2025: Unilabs, a top diagnostic services provider in Europe, has partnered with Oxipit, a leading medical imaging AI company, to implement AI-powered chest X-ray solutions across its

Latent Labs, a pioneering AI-driven biotech startup, has secured $50 million in funding to transform how proteins are designed. Latent Labs is at the forefront of an industry shift where scientists no longer just study biology, they program it.

The UK has firmly established itself as a global innovator. With remarkable progress in bioscience advancements and bio-pharma developments, the country continues to push the limits of what’s possible in modern healthcare.

Microfluidics is reshaping diagnostics, offering faster, more precise, and cost-effective solutions. However, the journey from breakthrough research to real-world applications comes with significant challenges. In a recent interview, Paul Marshall,

The £11 million government-funded trial, announced on World Cancer Day, will determine whether AI can analyse mammograms as accurately as human radiologists. If it proves successful, hospitals could cut their workload by 50% and speed up life-saving diagnoses.